Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease
暂无分享,去创建一个
D. Fliser | S. Wagenpfeil | S. Bode-Böger | G. Heine | A. Zawada | J. Martens-Lobenhoffer | I. Emrich